BioWorld
-
Arca’s COVID-19 bid sparks the stock
-
All eyes (virtually) focused on ASCO: Which companies will impress Wall Street?
-
ASCO analysis weighs cancer plus COVID-19 double whammy
-
Edigene, Immunochina betting on allogeneic CAR T therapy in cancer collaboration
-
Today's news in brief
-
Challenges posed to Chinese biotechs in post-pandemic era
-
Optimistic Sorrento looking to have COVID-19 antibody ready by October
-
Centrifugation can be child’s play with fidget spinners
-
Gold, plated: Arcus covenant with Gilead commands potential $2B chestful
BioWorld MedTech
-
Neural Analytics aims robotic transcranial doppler at COVID-19 patients
-
Presumption in favor of petitioner seen as most critical piece of PTO response to SAS v. Iancu
-
Today's news in brief
-
Izotropic, Starfish set to commercialize new breast CT system
-
BioWorld MedTech’s Diagnostics Extra for May 28, 2020
-
Kahala Biosciences, Rymedi bring blockchain to COVID-19 antibody testing
-
Philips debuts wearable vitals sign patch to monitor COVID-19 patients for early intervention
-
U.S. FDA encouraging COVID-19 test developers to file 510(k)s
-
Germline ApoE variants affect melanoma trajectory
BioWorld Asia
-
SK Group prepares IPO for subsidiary SK Biopharmaceuticals
-
After Ad5-nCoV, Cansino aims at mRNA vaccine for COVID-19 with Precision Nanosystems
-
News in brief
-
China’s Carsgen set to start trials for first claudin18.2-targeted CAR T-cell therapy
-
Zentalis Pharmaceuticals receives $20 million series A financing to set up Chinese JV
-
China’s Inmagene CEO: Cost-efficient innovation for global medical needs
-
Germline ApoE variants affect melanoma trajectory
-
Affibody lands potential $226M deal for ABY-035 in China
-
Daewon Pharma launches its first teriparatide biosimilar
